LTX-005

N/A

Report date: 2024/11/12 10:42:48
NME

Base Information

Drug NameLTX-005
Drug Alias NameLTX-005
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisense
Mechanisms of ActionGlutamate [NMDA] receptor modulators
TargetsGlutamate [NMDA] receptor
Therapy Area/IndicationsDepressive Disorder, Treatment-ResistantDepressive Disorder, MajorEpilepsy
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesLeal Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesLeal Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsDepressive Disorder, Treatment-ResistantDepressive Disorder, MajorEpilepsy
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A